site stats

Btai stock price target

WebApr 10, 2024 · Currently, the analyst consensus on Bioxcel Therapeutics is a Moderate Buy with an average price target of $46.00, a 168.8% upside from current levels. In a report issued on April 6, Mizuho... WebBTAI BioXcel Therapeutics Inc. Analyst Estimates & Rating – WSJ Sign In BioXcel Therapeutics Inc. BTAI (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT …

BioXcel Therapeutics Stock (NASDAQ:BTAI), Analyst Ratings, Price ...

WebBTAI has a higher average analyst price target than 2939.86% of stocks in the small market cap category. In the context of stocks in the small market cap category, BIOXCEL … WebApr 12, 2024 · BioXcel Therapeutics, Inc. ( NASDAQ:BTAI – Get Rating) Director Krishnan Nandabalan sold 60,000 shares of BioXcel Therapeutics stock in a transaction dated Thursday, April 6th. The shares were sold at an average price of $17.32, for a total transaction of $1,039,200.00. the source for dealer https://theyocumfamily.com

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Receives Consensus ...

WebMar 10, 2024 · BTAI Price Target For more insight on analysts targets of BTAI, see our BTAI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page. Average Price Target $92.55 Average Broker Recommendation 1.3 (Strong Buy) BTAI Stock Price Chart Interactive … Web1 day ago · Currently, the analyst consensus on Bioxcel Therapeutics is a Moderate Buy with an average price target of $49.33. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of... WebPrice To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for BioXcel Therapeutics (BTAI) myrtle pelicans baseball

BioXcel Therapeutics (BTAI) Price To Free Cash Flow

Category:BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Receives Consensus ...

Tags:Btai stock price target

Btai stock price target

BTAI stock gains as price target raised at BofA on FDA approval for ...

WebApr 12, 2024 · Discover historical prices for BTAI stock on Yahoo Finance. View daily, weekly or monthly format back to when BioXcel Therapeutics, Inc. stock was issued. WebApr 6, 2024 · According to 16 analysts, the average rating for BTAI stock is "Buy." The 12-month stock price forecast is $54.52, which is an increase of 215.51% from the latest …

Btai stock price target

Did you know?

WebMar 22, 2024 · Get The Latest BTAI Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content S&P 500 4,001.09(-0.04%) DOW 32,486.38(-0.23%) QQQ 311.07(+0.24%) AAPL 160.03(+0.47%) MSFT 277.05(+1.19%) META 204.05(+0.93%) GOOGL 105.30(+0.36%) AMZN 100.19(-0.42%) … WebPrice To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for BioXcel Therapeutics (BTAI)

WebBioXcel Therapeutics (NASDAQ:BTAI) had a huge reversal on big volume Thursday, popping 1.95, or 81%, to 4.36, on 2.7 million shares and closed at the upper end of the... BioXcel Therapeutics... WebBTAI Stock 12 Months Forecast. Average Price Target. $46.00. (146.52% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Bioxcel Therapeuticsin the last …

WebThe analyst firm set a price target for 66.00 expecting BTAI to rise to within 12 months (a possible 282.17% upside). 16 analyst firms have reported ratings in the last year. WebJul 26, 2024 · Recently, the Street’s analysts have tapped three stocks they see as long-term winners – but with low share value right now. According to TipRanks' database, these are Strong Buy stocks, featuring...

WebApr 9, 2024 · BTAI Price Target 2024 BioXcel Therapeutics Analyst Ratings NASDAQ:BTAI BioXcel Therapeutics - BTAI Price Target & Analyst Ratings $18.66 +0.06 (+0.32%) (As of 03/31/2024 12:00 AM ET) Compare Today's Range $18.34 $19.27 50 …

Web1 day ago · Currently, the analyst consensus on Bioxcel Therapeutics is a Moderate Buy with an average price target of $49.33. See Insiders’ Hot Stocks on TipRanks >> The … the source from which income is derivedWebMar 29, 2024 · BTAI Stock Price Targets and Analyst Ratings BioXcel Therapeutics Inc. Stock NASDAQ: BTAI Open Broker Account NASDAQ Stock Exchange > Healthcare > … the source for everything jewish catalogWebBioxcel Therapeutics (BTAI) Stock Price & Analysis 1,038 Followers BTAI Stock Chart & Stats Advanced Chart > Day’s Range $0 - $0 52-Week Range $8.80 - $34.13 Previous … myrtle piersall portsmouth vaWebApr 11, 2024 · Lowest-Rated Stocks NYSE:CVNA Carvana - CVNA Price Target & Analyst Ratings $8.93 +0.43 (+5.06%) (As of 04/6/2024 02:22 PM ET) Compare Today's Range $8.16 $9.00 50-Day Range $6.50 $14.45 52-Week Range $3.55 $116.15 Volume 5.13 million shs Average Volume 25.49 million shs Market Capitalization $1.69 billion P/E … myrtle philip schoolWebApr 10, 2024 · The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $50.00. A number of equities research analysts … the source ft candi statonWebMar 24, 2024 · According to 16 stock analysts, the average 12-month stock price forecast for BTAI stock is $ 57.03 , which predicts an increase of 211.30%. The lowest target is … the source furnishingsWebApr 6, 2024 · The price target raised to $80 per share is four times as large as the last closing price. BXCL501, the treatment identified as Igalmi after its FDA approval, is … myrtle physical description great gatsby